Immunoreactive peptides from Epstein-Barr virus

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7326535
APP PUB NO 20040013665A1
SERIAL NO

10442456

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Epstein-Barr virus (EBV) specific polypeptides are disclosed. Also disclosed are the use of these polypeptides for the production of polypeptide-specific antibodies and the diagnosis and treatment of EBV-associated disease.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GEORGETOWN UNIVERSITY37TH AND O STREETS NW WASHINGTON DC 20057
ORTHO DIAGNOSTICS SYSTEMS INC1001 U S ROUTE 202 RARITAN NJ 08869

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Parks, D Elliot Del Mar, CA 18 81
Pearson, Gary R Sedona, AZ 3 12
Smith, Richard S Salt Lake City, UT 94 1538
Varghese, Susan Pothen Melrose, MA 3 12

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation